论文部分内容阅读
高脂血症作为冠心病（ＣＨＤ）的重要危险因素已得到肯定。降低血清总胆固醇（ＴＣ）水平可降低ＣＨＤ的患病率和病死率［１］，３羟３甲基戊二酰辅酶Ａ还原酶抑制剂是目前最有效的一类调脂药，国产洛伐他丁（罗华宁，ｌｏｖａｓｔａｔｉｎ），临床推荐剂量２０ｍｇ／ｄ。?
Hyperlipidemia as an important risk factor for coronary heart disease (CHD) has been affirmed. Lower serum total cholesterol (TC) levels can reduce the prevalence of CHD and mortality [1], 3 hydroxy 3 methylglutaryl coenzyme A reductase inhibitor is the most effective class of lipid-lowering drugs, made in China Lovastatin (lovastatin), the clinical recommended dose of 20mg / d. ?